http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/alcon-laboratories-issues-voluntary-nationwide-recall-one-1-lot-systane-lubricant-eye-drops-ultra-pf

http://www.fda.gov/medical-devices/medical-device-recalls/early-alert-endoscope-accessories-forcepsirrigation-plug-issue-olympus

FDA Approves First Medication for Obstructive Sleep Apnea
http://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea

FDA Roundup: December 20, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-20-2024

FDA Approves First Acellular Tissue Engineered Vessel to Treat Vascular Trauma in Extremities
http://www.fda.gov/news-events/press-announcements/fda-approves-first-acellular-tissue-engineered-vessel-treat-vascular-trauma-extremities

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/endo-usa-inc-issues-voluntary-nationwide-recall-adrenalinr-chloride-solution-epinephrine-nasal

http://www.fda.gov/medical-devices/medical-device-recalls/early-alert-nephroscope-sheath-issue-trokamed-gmbh

FDA Updates “Healthy” Claim, Providing a Refreshed Tool for Consumers
http://www.fda.gov/news-events/press-announcements/fda-updates-healthy-claim-providing-refreshed-tool-consumers

FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease
http://www.fda.gov/news-events/press-announcements/fda-approves-first-mesenchymal-stromal-cell-therapy-treat-steroid-refractory-acute-graft-versus-host

http://www.fda.gov/medical-devices/medical-device-recalls/hologic-inc-recalls-biozorb-marker-due-complications-implanted-devices